These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28623875)

  • 21. A case of bullous pemphigoid complicated by mucosal lesions due to mucosal-dominant pemphigus vulgaris: analyzing the pathogenicity of anti-desmoglein 3 antibodies using a bead aggregation assay.
    Yoshida K; Imai A; Kurita T; Ishii K; Ishiko A
    Int J Dermatol; 2024 Jul; 63(7):956-958. PubMed ID: 38741281
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-pathogenic anti-desmoglein 3 IgG autoantibodies in Fogo Selvagem.
    Amagai M
    J Invest Dermatol; 2006 Sep; 126(9):1931-2. PubMed ID: 16912688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
    Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
    Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
    [No Abstract]   [Full Text] [Related]  

  • 25. Two cases of pemphigus vulgaris in remission showing high titer of anti-desmoglein 3 antibodies.
    Inaoki M; Oishi K; Nishijima C; Takehara K; Ishii K
    J Dermatol; 2019 Mar; 46(3):e92-e94. PubMed ID: 30144149
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetylcholine receptor antibodies in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up.
    Tirado-Sánchez A; Vázquez-González D; Ponce-Olivera RM; López-Lozano HE
    Dermatol Online J; 2012 May; 18(5):14. PubMed ID: 22630584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orodigital pemphigus vulgaris: a pathogenic role of anti-desmoglein-3 autoantibodies in pemphigus paronychia?
    Laffitte E; Panizzon RG; Borradori L
    Dermatology; 2008; 217(4):337-9. PubMed ID: 18799879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Desmoglein 1 and 3 Autoantibody Levels in Endemic Pemphigus Foliaceus and Pemphigus Vulgaris from Brazil.
    Oliveira LA; Marquart-Filho A; Trevilato G; Timoteo RP; Mukai M; Roselino AM; Petzl-Erler ML
    Clin Lab; 2016 Jul; 62(7):1209-1216. PubMed ID: 28164651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
    Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
    J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
    Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K
    J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.
    Eming R; Rech J; Barth S; Kalden JR; Schuler G; Harrer T; Hertl M
    Dermatology; 2006; 212(2):177-87. PubMed ID: 16484825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
    Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
    J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression.
    Abidi NY; Lainiotis I; Malikowski G; Seiffert-Sinha K; Sinha AA
    J Drugs Dermatol; 2017 Feb; 16(2):135-139. PubMed ID: 28300855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission.
    Daneshpazhooh M; Zafarmand Sedigh V; Balighi K; Hosseini SH; Ramezani A; Kalantari MS; Ghandi N; Ghiasi M; Nikoo A; Chams-Davatchi C
    J Am Acad Dermatol; 2016 Jun; 74(6):1160-5. PubMed ID: 26896293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris.
    Weitz D; Bystryn JC
    Arch Dermatol; 2007 Aug; 143(8):1073-4. PubMed ID: 17709673
    [No Abstract]   [Full Text] [Related]  

  • 37. Osteopontin, a protein with cytokine-like properties: a possible involvement in pemphigus vulgaris.
    Baroni A; De Filippis A; Buommino E; Satriano RA; Cozza V
    Arch Dermatol Res; 2012 Apr; 304(3):237-40. PubMed ID: 22037626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score.
    Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D
    Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab in pemphigus foliaceous with autoantibodies against both Desmoglein 1 and Desmoglein 3.
    Carvalho R; Maio P; Cunha D; Freitas I; Afonso A; Cardoso J
    Eur J Dermatol; 2011; 21(3):415-6. PubMed ID: 21527367
    [No Abstract]   [Full Text] [Related]  

  • 40. Enzyme-linked immunosorbent assay as a helpful diagnostic tool for pemphigus erythematosus with equivocal histologic and immunofluorescent findings.
    Desai A; Harris J; Motaparthi K
    Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.